Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Dual role of human cytochrome P450 3A4 residue Phe-304 in substrate specificity and cooperativity.

Domanski TL, He YA, Harlow GR, Halpert JR.

J Pharmacol Exp Ther. 2000 May;293(2):585-91.

PMID:
10773032
2.

2,2',3,3',6,6'-hexachlorobiphenyl hydroxylation by active site mutants of cytochrome P450 2B1 and 2B11.

Waller SC, He YA, Harlow GR, He YQ, Mash EA, Halpert JR.

Chem Res Toxicol. 1999 Aug;12(8):690-9.

PMID:
10458702
3.

Use of the steroid derivative RPR 106541 in combination with site-directed mutagenesis for enhanced cytochrome P-450 3A4 structure/function analysis.

Stevens JC, Domanski TL, Harlow GR, White RB, Orton E, Halpert JR.

J Pharmacol Exp Ther. 1999 Aug;290(2):594-602.

PMID:
10411567
6.

Structural determinants of progesterone hydroxylation by cytochrome P450 2B5: the role of nonsubstrate recognition site residues.

He YQ, Harlow GR, Szklarz GD, Halpert JR.

Arch Biochem Biophys. 1998 Feb 15;350(2):333-9.

PMID:
9473309
7.
8.

Isolation, heterologous expression and functional characterization of a novel cytochrome P450 3A enzyme from a canine liver cDNA library.

Fraser DJ, Feyereisen R, Harlow GR, Halpert JR.

J Pharmacol Exp Ther. 1997 Dec;283(3):1425-32.

PMID:
9400018
9.

Functional interaction between amino-acid residues 242 and 290 in cytochromes P-450 2B1 and 2B11.

Harlow GR, He YA, Halpert JR.

Biochim Biophys Acta. 1997 Apr 4;1338(2):259-66.

PMID:
9128144
11.

Escherichia coli expression and substrate specificities of canine cytochrome P450 3A12 and rabbit cytochrome P450 3A6.

Born SL, Fraser DJ, Harlow GR, Halpert JR.

J Pharmacol Exp Ther. 1996 Aug;278(2):957-63.

PMID:
8768753
12.
13.

Arabidopsis mutants deficient in T-DNA integration.

Sonti RV, Chiurazzi M, Wong D, Davies CS, Harlow GR, Mount DW, Signer ER.

Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11786-90.

15.

Radiation-sensitive mutants of Arabidopsis thaliana.

Jenkins ME, Harlow GR, Liu Z, Shotwell MA, Ma J, Mount DW.

Genetics. 1995 Jun;140(2):725-32.

16.

Identification of high affinity binding sites for LexA which define new DNA damage-inducible genes in Escherichia coli.

Lewis LK, Harlow GR, Gregg-Jolly LA, Mount DW.

J Mol Biol. 1994 Aug 26;241(4):507-23.

PMID:
8057377
17.

Site-directed mutagenesis of putative substrate recognition sites in cytochrome P450 2B11: importance of amino acid residues 114, 290, and 363 for substrate specificity.

Hasler JA, Harlow GR, Szklarz GD, John GH, Kedzie KM, Burnett VL, He YA, Kaminsky LS, Halpert JR.

Mol Pharmacol. 1994 Aug;46(2):338-45.

PMID:
8078495
18.

Isolation of uvh1, an Arabidopsis mutant hypersensitive to ultraviolet light and ionizing radiation.

Harlow GR, Jenkins ME, Pittalwala TS, Mount DW.

Plant Cell. 1994 Feb;6(2):227-35.

19.

Letter: Spread of hepatitis in dialysis units.

Moore B, Cartwright RY, Bisson PG, Tratt J, Tyrrell DA, Dark FA, Harper GJ, Hutchison JG, Robertson MJ, Flewett TH, Jones DM, Tobin BM, Harlow GR.

Lancet. 1974 Oct 5;2(7884):842. No abstract available.

PMID:
4138398
20.

Antibody production in patients on regular haemodialysis to organisms present in dialysate.

Jones DM, Tobin BM, Harlow GR, Ralston AJ.

Proc Eur Dial Transplant Assoc. 1972;9:575-6. No abstract available.

PMID:
4668932
21.

Infections of Scribner and Brescia arteriovenous shunts.

Ralston AJ, Harlow GR, Jones DM, Davis P.

Br Med J. 1971 Aug 14;3(5771):408-9.

22.

Bacteriological studies of the modified Kiil dialyser.

Jones DM, Tobin BM, Harlow GR, Ralston AJ.

Br Med J. 1970 Jul 18;3(5715):135-7.

Supplemental Content

Loading ...
Support Center